KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Gross Margin (2016 - 2025)

Teladoc Health (TDOC) has disclosed Gross Margin for 12 consecutive years, with 69.32% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 118.0% to 69.32% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 80.55% through Dec 2025, up 979.0% year-over-year, with the annual reading at 69.5% for FY2025, 126.0% down from the prior year.
  • Gross Margin hit 69.32% in Q4 2025 for Teladoc Health, down from 92.3% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 140.54% in Q4 2021 to a low of 10.13% in Q4 2022.
  • Historically, Gross Margin has averaged 76.39% across 5 years, with a median of 70.62% in 2024.
  • Biggest five-year swings in Gross Margin: surged 12682bps in 2021 and later plummeted -13041bps in 2022.
  • Year by year, Gross Margin stood at 140.54% in 2021, then crashed by -93bps to 10.13% in 2022, then skyrocketed by 807bps to 91.91% in 2023, then decreased by -23bps to 70.5% in 2024, then fell by -2bps to 69.32% in 2025.
  • Business Quant data shows Gross Margin for TDOC at 69.32% in Q4 2025, 92.3% in Q3 2025, and 92.1% in Q2 2025.